CNN The Situation Room With Wolf Blitzer April 30, 2021 22:46:00
Advanced non-small cell lung cancer can change everything. but your first treatment could be a chemo-free combination of two immunotherapies that works differently. it could mean a chance to live longer. opdivo plus yervoy is for adults newly diagnosed with non-small cell lung cancer that has spread, tests positive for pd-l1 and does not have an abnormal egfr or alk gene. opdivo plus yervoy is the only fda-approved combination of two immunotherapies